Showing results (1911-1920 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|July 26, 2002
A benefit-risk assessment of misoprostol for cervical ripening and labour inductionDeborah A Wing
Drug Safety|May 2, 2000
Dobutamine stress echocardiography: safety in diagnosing coronary artery diseaseF Lattanzi, E Picano, E Adamo, et al.
Drug Safety|December 24, 2002
Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to dateJean-Pierre Cosyns
Drug Safety|December 24, 2002
Adverse events associated with rofecoxib therapy: results of a large study in community-derived osteoarthritic patientsBernard Bannwarth, Richard Trèves, Liana Euller-Ziegler, et al.
Drug Safety|January 22, 2003
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regionsRoberto Leone, Mauro Venegoni, Domenico Motola, et al.
Drug Safety|January 22, 2003
The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in EnglandLynda V Wilton, Cheryl Key, Saad A W Shakir
Drug Safety|May 22, 2002
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and managementDouglas E Moore
Drug Safety|April 12, 2003
Potentially significant drug interactions of class III antiarrhythmic drugsWeeranuj Yamreudeewong, Michael DeBisschop, Linda G Martin, et al.
Drug Safety|April 12, 2003
Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysisMahyar Etminan, Sudeep Gill, Ali Samii
Drug Safety|May 9, 2003
Benefits and risks of pharmacological treatments for essential tremorKelly E Lyons, Rajesh Pahwa, Cynthia L Comella, et al.
Pageof 311